Conestoga Capital Advisors, an asset administration firm, launched its second-quarter 2025 investor letter. A duplicate of the letter could be downloaded right here. The second quarter started with a traditionally poor begin however gained momentum later as tariff fears subsided and market volatility dropped precipitously. Conestoga Mid Cap Composite returned 3.46% net-of-fees within the quarter, trailing the Russell Mid Cap Progress Index’s 18.20% return. After a powerful first quarter in 2025, investor enthusiasm shifted in direction of high-beta and AI shares following the “Liberation Day” bulletins, making a slim management group that posed challenges for the Mid Cap Technique within the second quarter. Please evaluate the fund’s prime 5 holdings to realize perception into their key picks for 2025.
In its second quarter 2025 investor letter, Conestoga Capital Advisors highlighted shares comparable to IDEXX Laboratories, Inc. (NASDAQ:IDXX). IDEXX Laboratories, Inc. (NASDAQ:IDXX) develops, manufactures, and distributes merchandise primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets. The one-month return of IDEXX Laboratories, Inc. (NASDAQ:IDXX) was 5.38%, and its shares gained 19.58% of their worth over the past 52 weeks. On July 25, 2025, IDEXX Laboratories, Inc. (NASDAQ:IDXX) inventory closed at $565.19 per share, with a market capitalization of $45.454 billion.
Conestoga Capital Advisors acknowledged the next concerning IDEXX Laboratories, Inc. (NASDAQ:IDXX) in its second quarter 2025 investor letter:
“IDEXX Laboratories, Inc. (NASDAQ:IDXX) is the trade chief in offering devices (and consumables) utilized in diagnostics, detection, and data methods for veterinary, meals, and water testing functions. Earnings for the quarter had been strong and steerage for high-single-digit natural income progress was maintained, regardless of weak visitors traits. Shares rallied off five-year low valuation and the ‘better-than-feared’ ends in the quarter.”
A veterinarian in a veterinary clinic analyzing a companion animal.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) just isn’t on our record of 30 Most Fashionable Shares Amongst Hedge Funds. As per our database, 51 hedge fund portfolios held IDEXX Laboratories, Inc. (NASDAQ:IDXX) on the finish of the primary quarter, which was 58 within the earlier quarter. Within the first quarter of 2025, IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported natural income progress of 5% pushed by 4.5% natural income good points within the CAG enterprise, 7% natural progress in water, and 4% natural progress in LPD. Whereas we acknowledge the potential of IDEXX Laboratories, Inc. (NASDAQ:IDXX) as an funding, we consider sure AI shares provide higher upside potential and carry much less draw back danger. In case you’re on the lookout for an especially undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring pattern, see our free report on the finest short-term AI inventory.